scholarly journals Detection of the Phoma pathogens Plenodomus biglobosus subclades ‘brassicae’ and ‘canadensis’ on wasabi, and ‘canadensis’ in Europe

Author(s):  
Kevin M. King ◽  
Jonathan S. West

Abstract Phoma stem canker / blackleg is an internationally important disease of Brassicas including B. napus (oilseed rape, OSR), caused by multiple genetic subclades of the fungi Plenodomus lingam (formerly Leptosphaeria maculans) and P. biglobosus (L. biglobosa). In Spring 2021, Phoma-like disease symptoms were observed on leaves and stems of Eutrema japonicum (wasabi) crops at three UK sites (Northern Ireland, Southern England and the West Midlands). Fungal isolation from wasabi leaf spots yielded colonies with two distinct phenotypes on potato dextrose agar (PDA). Isolates from the Northern Ireland and Southern England sites had white colonies with abundant pink cirri that were confirmed (based on ITS rDNA, beta tubulin and actin sequences) as P. biglobosus subclade ‘canadensis’ (Pbc). Those from the West Midlands site, however, had yellow pigmented colonies and were confirmed by sequencing as P. biglobosus subclade ‘brassicae’ (Pbb). Greenhouse pathogenicity testing showed that Pbb and Pbc wasabi isolates were pathogenic not only to this host but also OSR, B. oleracea (cabbage), and B. rapa (pak choi). Re-isolation of the fungi was attempted and confirmed from lesions that developed on inoculated OSR and wasabi, thus completing Koch’s postulates. These findings represent new discoveries for both Pbb and Pbc on wasabi, plus for Pbc in Europe. The crop health implications of these results are briefly considered.

2008 ◽  
Vol 90 (5) ◽  
pp. 162-163
Author(s):  
Louisa Hermans

The College is embarking on an exciting new venture to pilot a local structure to support surgeons in the workplace. Its aim is to provide a unified voice for surgery in relation to service delivery and professional standards, and to support individual surgeons through the revalidation process and with their continuing professional development (CPD). It is currently being piloted within the West Midlands and South West Strategic Health Authority (SHA) boundaries for one year. During this time it will be rigorously evaluated to determine its suitability and whether or not it will be implemented across England, Wales and Northern Ireland in the long term.


Sign in / Sign up

Export Citation Format

Share Document